The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Open accessAbstract
Activating mutations in GNAQ/GNA11, encoding Gαq G proteins, are initiating oncogenic events in uveal melanoma (UM). However, there are no effective therapies for UM. Using an integrated bioinformatics pipeline, we found that PTK2, encoding focal adhesion kinase (FAK), represents a candidate synthetic lethal gene with GNAQ activation. We show that Gαq activates FAK through TRIO-RhoA non-canonical Gαq-signaling, and genetic ablation or pharmacological inhibition of FAK inhibits UM growth. Analysis of the FAK-regulated transcriptome demonstrated that GNAQ stimulates YAP through FAK. Dissection of the underlying mechanism revealed that FAK regulates YAP by tyrosine phosphorylation of MOB1, inhibiting core Hippo signaling. Our findings establish FAK as a potential therapeutic target for UM and other Gαq-driven pathophysiologies that involve unrestrained YAP function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, FAK was reported to positively regulate YAP activity through tyrosine phosphorylation of the YAP upstream modulator MOB1, then dissociating the MOB1/LATS complex.[ 31, 32 ]”
From Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling (2021) · cites this paper as [31]
In the citing paper
“FAK is known to activate and accumulate YAP in cell nucleus through its regulation of the MOB1/LATS1/2 complex, which is an upstream biomarker of YAP signaling[ 31, 32 ]”
From Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK–YAP Signaling (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationIntegrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Self-citationThe cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
Modeling Survival Data: Extending the Cox Model
Therneau, T. M., & Grambsch, P. M. (2000) · Statistics for Biology and Health · doi:10.1007/978-1-4757-3294-8 · Cited by 8,674
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Defining a Cancer Dependency Map
Tsherniak, A., Vazquez, F., Montgomery, P. G., Weir, B. A., Kryukov, G., Cowley, G. S., Gill, S., Harrington, W. F., Pantel, S., Krill-Burger, J. M., et al. (2017) · Cell · doi:10.1016/j.cell.2017.06.010 · Cited by 3,276
TEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498
Systematic identification of genomic markers of drug sensitivity in cancer cells
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., et al. (2012) · Nature · doi:10.1038/nature11005 · Cited by 2,456
The Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,317
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 238
Cheng, K., Nair, N. U., Lee, J. S., & Ruppin, E. (2021) · Science Advances · doi:10.1126/sciadv.abc2100 · Cited by 17
Self-citationOnken, M. D., Blumer, K., & Cooper, J. A. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-04-0241 · Cited by 17
Tarin, M., Némati, F., Decaudin, D., Canbezdi, C., Marande, B., Silva, L. E., Derrien, H., Jochemsen, A. G., Gardrat, S., Piperno-Neumann, S., et al. (2023) · Cancers · doi:10.3390/cancers15082280 · Cited by 14
Publication trends of research on uveal melanoma during 2000–2020: a 20-year bibliometric study
Xie, M., Wu, Q., Wang, Y., Ge, S., & Fan, X. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-3700 · Cited by 16
MOB: Pivotal Conserved Proteins in Cytokinesis, Cell Architecture and Tissue Homeostasis
Delgado, I. L. S., Carmona, B., Nolasco, S., Santos, D., Leitão, A., & Soares, H. (2020) · Biology · doi:10.3390/biology9120413 · Cited by 16
KITlow Cells Mediate Imatinib Resistance in Gastrointestinal Stromal Tumor
Banerjee, S., Yoon, H., Ting, S., Tang, C., Yebra, M., Wenzel, A. T., Yeerna, H., Mesirov, J. P., Wechsler‐Reya, R. J., Tamayo, P., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0973 · Cited by 15
Self-citationNovel Approaches to the Systemic Management of Uveal Melanoma
Khan, S. A., & Carvajal, R. D. (2020) · Current Oncology Reports · doi:10.1007/s11912-020-00965-0 · Cited by 16
Integrated, Longitudinal Analysis of Cell-free DNA in Uveal Melanoma
Wong, D., Luo, P., Znassi, N., Arteaga, D. P., Gray, D., Danesh, A., Han, M., Stutheit-Zhao, E. Y., Pedersen, S., Prokopec, S. D., et al. (2023) · Cancer Research Communications · doi:10.1158/2767-9764.crc-22-0456 · Cited by 16
Targeting the Hippo Pathway in Prostate Cancer: What’s New?
Coffey, K. (2021) · Cancers · doi:10.3390/cancers13040611 · Cited by 15
Specific human endogenous retroviruses predict metastatic potential in uveal melanoma
Bendall, M. L., Francis, J. H., Shoushtari, A. N., & Nixon, D. F. (2022) · JCI Insight · doi:10.1172/jci.insight.147172 · Cited by 15
Gao, J., Yao, Y., Liu, C., Xi, X., Li, D., Liu, P., Wang, Z., Zhang, B., & Ren, R. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.81918 · Cited by 15
Self-citationMechanism and application of feedback loops formed by mechanotransduction and histone modifications
Sun, H., Gao, Y., Ma, X., Deng, Y., Bi, L., & Li, L. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2023.06.030 · Cited by 15
YAP at the Crossroads of Biomechanics and Drug Resistance in Human Cancer
Huang, M. L., Wang, H., Mackey, C., Chung, M. C., Guan, J., Zheng, G., Roy, A., Xie, M., Vulpe, C. D., & Tang, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512491 · Cited by 14
Activation of skeletal muscle FAPs by LPA requires the Hippo signaling via the FAK pathway
Cruz-Soca, M., Faundez-Contreras, J., Córdova-Casanova, A., Gallardo, F. S., Bock-Pereda, A., Chun, J. J. M., Casar, J. C., & Brandan, E. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.03.010 · Cited by 15
Kerselidou, D., Dohai, B., Nelson, D. R., Daakour, S., Cock, N. D., Hassoun, Z. E. O., Kim, D., Olivet, J., Assal, D. C. E., Jaiswal, A. K., et al. (2021) · Science Advances · doi:10.1126/sciadv.abe8349 · Cited by 15
FAK mediates mechanical signaling to maintain epithelial homeostasis through YAP/TAZ-TEADs
Yang, P., Yuan, Q., Zhou, S., Gan, J., Shen, Z., Xia, X., Jiang, Y., Chen, Q., Yao Zong, Y. U. A. N., He, R., et al. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02360-x · Cited by 13
Self-citationBACH1 promotes lung adenocarcinoma cell metastasis through transcriptional activation of ITGA2
Chen, Y., Jin, L., Ma, Y., Liu, Y., Zhu, Q., Huang, Y., & Feng, W. (2023) · Cancer Science · doi:10.1111/cas.15884 · Cited by 13
Pan, P., Li, J., Wang, B., Tan, X., Yin, H., Han, Y., Wang, H., Shi, X., Li, X., Xie, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1067849 · Cited by 13
Biological characteristics and clinical management of uveal and conjunctival melanoma
Kaštelan, S., Pavičić, A. D., Pašalić, D., Nikuševa-Martić, T., Čanović, S., Kovačević, P., & Konjevoda, S. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.048437 · Cited by 12
Pilch, J., Mizera, J., Tota, M., & Donizy, P. (2024) · Cancers · doi:10.3390/cancers16213672 · Cited by 12
Zhang, Q., Shi, M., Zheng, R., Han, H., Zhang, X., & Lin, F. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175935 · Cited by 12
Huber, T., Horioka-Duplix, M., Chen, Y., Saca, V. R., Ceraudo, E., Chen, Y., & Sakmar, T. P. (2024) · Science Signaling · doi:10.1126/scisignal.adp3967 · Cited by 12
Diosmin reduces the stability of Snail and Cyclin D1 by targeting FAK to inhibit NSCLC progression
Ma, C., Dan, M., Wang, Y., Shu, C., Jiao, M., Shao, Y., Zhang, H., Li, C., Zeng, Y., Zhu, J., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156135 · Cited by 11
The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer
Zhong, B., Du, J., Liu, F., & Sun, S. (2025) · MedComm · doi:10.1002/mco2.70128 · Cited by 10
Zhang, Y., Zhang, B., Li, Y., Dai, Y., Li, J., Li, D., Xia, Z., Zhang, J., Liu, P., Chen, M., et al. (2022) · Frontiers of Medicine · doi:10.1007/s11684-021-0911-0 · Cited by 11
Zhang, K., Zhu, H., Sun, Q., Yang, J., Zhao, G., Wei, Q., Lin, M., Cao, Y., & Bian, L. (2025) · Materials Today · doi:10.1016/j.mattod.2025.08.020 · Cited by 10
Goto, Y., Koshizuka, K., Ando, T., Izumi, H., Wu, X., Sato, K., Ishikawa, T., Ford, K. M., Feng, X., Wang, Z., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0247 · Cited by 10
Self-citationDelgado‐Bellido, D., Chacón-Barrado, A., Olmedo-Pelayo, J., Perez, C. J., Gilabert-Prieto, P., Díaz‐Martín, J., García-Díaz, Á., Oliver, F. J., & de Álava, E. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-025-01469-9 · Cited by 10
He, C. H., Wang, T., Wang, Y., Xu, T., Zhao, S., Shi, H., & Zou, R. (2021) · Oral Diseases · doi:10.1111/odi.13997 · Cited by 10
ELISL: early–late integrated synthetic lethality prediction in cancer
Tepeli, Y. I., Seale, C., & Gonçalves, J. P. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad764 · Cited by 11
Phosphorylation analysis of the Hippo-YAP pathway using Phos-tag
Kim, C.-L., Lim, S., Kim, K., Jeong, H.-S., & Mo, J. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104582 · Cited by 11
Regulator of G protein signaling 2 inhibits Gαq-dependent uveal melanoma cell growth
Zhang, Q., Haak, A. J., & Sjögren, B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101955 · Cited by 10
Kim, Y. J., Park, S. J., Maeng, K. J., Lee, S. C., & Lee, C. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-55513-z · Cited by 10
Banimohammad, M., Khalafi, P., Gholamin, D., Bangaleh, Z., Akhtar, N., Solomon, A. D., Prabhakar, P. K., Sanami, S., Prakash, A., & Pazoki–Toroudi, H. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002306 · Cited by 9
Cytoskeletal Remodelling as an Achilles’ Heel for Therapy Resistance in Melanoma
Barreno, A., & Orgaz, J. L. (2022) · Cells · doi:10.3390/cells11030518 · Cited by 9
Overcoming selection bias in synthetic lethality prediction
Seale, C., Tepeli, Y. I., & Gonçalves, J. P. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac523 · Cited by 9
Uveal melanoma modeling in mice and zebrafish
van den Bosch, Q. C. C., de Klein, A., Verdijk, R. M., Kılıç, E., & Brosens, E. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189055 · Cited by 8
Notochord segmentation in zebrafish controlled by iterative mechanical signaling
Wopat, S., Adhyapok, P., Daga, B., Crawford, J. M., Norman, J., Bagwell, J., Peskin, B., Magre, I., Fogerson, S. M., Levic, D. S., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.04.013 · Cited by 9
Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma
Baqai, U., Kurimchak, A., Trachtenberg, I. V., Purwin, T. J., Haj, J. I., Han, A., Luo, K., Pachon, N. F., Jeon, A., Chua, V. Y. L., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105418 · Cited by 8
Self-citationUveal melanoma: laboratory advances and new frontiers in patient care
Xu, T. T., Moser, J. C., & Dalvin, L. A. (2021) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000744 · Cited by 8
Chaim, O. M., Miki, S., Prager, B. C., Ma, J., Jeong, A. Y., Lara, J., Tran, N. K., Smith, J. M., Rich, J. N., Gutkind, J. S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-49164-4 · Cited by 8
Self-citationSynthetic lethality-based prediction of anti-SARS-CoV-2 targets
Pal, L. R., Cheng, K., Nair, N. U., Martin‐Sancho, L., Sinha, S., Pu, Y., Riva, L., Yin, X., Schischlik, F., Lee, J. S., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104311 · Cited by 8
Self-citationMurphy, J. M., Jeong, K., Ahn, E.-Y. E., & Lim, S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102013 · Cited by 8
Ando, T., Okamoto, K., Shintani, T., Yanamoto, S., Miyauchi, M., Gutkind, J. S., & Kajiya, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12101544 · Cited by 8
Self-citationZhang, G., Huang, S., Ye, L.-X., Liu, X., Shi, W.-H., Ren, Z., Zhou, R., Zhang, J., Pan, J., Liu, S., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106464 · Cited by 8
Onken, M. D., Erdmann-Gilmore, P., Zhang, Q., Thapa, K., King, E. M., Kaltenbronn, K. M., Noda, S. E., Makepeace, C. M., Goldfarb, D., Babur, Ö., et al. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100649 · Cited by 8
The Molecular Pathology of Eye Tumors: A 2019 Update Main Interests for Routine Clinical Practice
Nahon‐Estève, S., Martel, A., Maschi, C., Caujolle, J., Baillif, S., Lassalle, S., & Hofman, P. M. (2019) · Current Molecular Medicine · doi:10.2174/1566524019666190726161044 · Cited by 8
Uveal Melanoma: Molecular and Genetic Mechanisms of Development and Therapeutic Approaches
Zhilnikova, M., Troitskaya, O. S., Novak, D. D., Atamanov, V. V., & Koval, O. A. (2024) · Molecular Biology · doi:10.1134/s0026893324020183 · Cited by 7
Xu, S., Jiang, H., & Zhang, P. (2024) · International Journal of Pharmacology · doi:10.3923/ijp.2024.1087.1097 · Cited by 7
Chai, P., Yu, J., Li, Y., Shi, Y., Fan, X., & Jia, R. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.107916 · Cited by 7
Beta-arrestins operate an on/off control switch for focal adhesion kinase activity
Alexander, R. A., Lot, I., Saha, K., Abadie, G., Lambert, M., Decosta, E., Kobayashi, H., Beautrait, A., Borrull, A., Asnacios, A., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03471-5 · Cited by 7
Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics
Chen, J., Bu, Z., & Zhan, Q. (2026) · 中国科学通报:英文版 · doi:10.1016/j.scib.2026.02.048 · Cited by 7
Trogdon, M., Abbott, K. L., Arang, N., Lande, K., Kaur, N., Tong, M. M., Bakhoum, M. F., Gutkind, J. S., & Stites, E. C. (2024) · npj Systems Biology and Applications · doi:10.1038/s41540-024-00400-1 · Cited by 7
Self-citationGoing Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gα in Human Cancer
Dwyer, M. B., Aumiller, J. L., & Wedegaertner, P. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000743 · Cited by 5
Jiang, H., Shi, S., Zhang, S., Zheng, J., & Li, Q. (2024) · IEEE Transactions on Visualization and Computer Graphics · doi:10.1109/tvcg.2024.3456325 · Cited by 8
An Agrin–YAP/TAZ Rigidity Sensing Module Drives EGFR‐Addicted Lung Tumorigenesis
Mokhtari, R. B., Sampath, D., Eversole, P., Lin, M. O. Y., Bosykh, D. A., Boopathy, G. T. K., Sivakumar, A., Wang, C., Kumar, R., Sheng, J. Y. P., et al. (2025) · Advanced Science · doi:10.1002/advs.202413443 · Cited by 8
Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
Randolph, C. E., Dwyer, M. B., Aumiller, J. L., Dixon, A. J., Inoue, A., Osei‐Owusu, P., & Wedegaertner, P. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102538 · Cited by 6
Causes, consequences and clinical significance of aneuploidy across melanoma subtypes
Shteinman, E. R., Wilmott, J. S., da Silva, I. P., Long, G. V., Scolyer, R. A., & Vergara, I. A. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.988691 · Cited by 6
Lapadula, D., Lam, B., Terai, M., Sugase, T., Tanaka, R., Farias, E., Kadamb, R., Lopez-Anton, M., Heine, C. C., Modasia, B., et al. (2022) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-22-0147 · Cited by 7
Combined Mcl-1 and YAP1/TAZ inhibition for treatment of metastatic uveal melanoma
Glinkina, K., Teunisse, A. F. A. S., Gelmi, M. C., de Vries, J., Jager, M. J., & Jochemsen, A. G. (2023) · Melanoma Research · doi:10.1097/cmr.0000000000000911 · Cited by 6
Longakit, A. N., Urtatiz, O., Luty, A., Zhang, C., Hess, C., Yoo, A., Bourget, H., & Raamsdonk, C. D. V. (2025) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0386 · Cited by 5
Comito, F., Marchese, P. V., Ricci, A. D., Tober, N., Peterle, C., Sperandi, F., & Melotti, B. (2021) · Future Oncology · doi:10.2217/fon-2021-0318 · Cited by 5
Mechanotransduction in fibrosis: Mechanisms and treatment targets
Yeh, C., Chou, C. E. N., & Yang, K. (2021) · Current topics in membranes · doi:10.1016/bs.ctm.2021.07.004 · Cited by 4
Phelps, G. B., Amsterdam, A., Hagen, H. R., García, N. Z., & Lees, J. A. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13057 · Cited by 5
Aumiller, J. L., & Wedegaertner, P. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.102880 · Cited by 5
Merlin–YAP signaling: emerging mechanisms, functions, and therapeutic approaches
Guo, P. (2025) · Trends in Cell Biology · doi:10.1016/j.tcb.2025.09.001 · Cited by 5
PTK2 promotes uveal melanoma metastasis by activating epithelial‐to‐mesenchymal transition
Luo, P., Duan, J., Chen, Q., Shao, L., Xiao, W., Liu, X., Zhang, G., Tan, X., & Fan, Z. (2023) · MedComm – Oncology · doi:10.1002/mog2.44 · Cited by 4
Self-citationRecent advances in the molecular genetic mechanisms and immune microenvironment of uveal melanoma
Yang, K., & Wu, D. (2026) · Melanoma Research · doi:10.1097/cmr.0000000000001089 · Cited by 4
Hippo signaling in cancer: regulatory mechanisms and therapeutic strategies
Huang, Z., Tan, Y., Zhang, W., Tang, X., Nice, E. C., & Huang, C. (2023) · Australian Journal of Chemistry · doi:10.1071/ch22241 · Cited by 4
Zhang, Z., Wang, X., Liu, Y., Wu, H., Zhu, X., Ye, C., Ren, H., Chong, W., Shang, L., & Li, L. (2024) · MedComm · doi:10.1002/mco2.472 · Cited by 5
GZ17-6.02 kills PDX isolates of uveal melanoma
Booth, L. A., Roberts, J. L., Spasojević, I., Baker, K. C., Poklepovic, A. S., West, C. E., Kirkwood, J. M., & Dent, P. (2024) · Oncotarget · doi:10.18632/oncotarget.28586 · Cited by 4
New Mechanisms Underlying Oncogenesis in Dbl Family Rho Guanine Nucleotide Exchange Factors
Ravala, S. K., & Tesmer, J. J. G. (2024) · Molecular Pharmacology · doi:10.1124/molpharm.124.000904 · Cited by 4
Wang, T., Tong, H., Chen, R., Jiang, Y., Zhang, C., Qi, H., & Zhang, X. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.151788 · Cited by 3
Zhou, Q., Zhang, Y., Gong, Y., Chen, L., Zhang, Q., Chen, Y., Zhao, M., Zhang, B., Liu, Z., Zhang, B., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.218211 · Cited by 5
Juan-Guadarrama, D. G., Beltrán‐Navarro, Y. M., Reyes‐Cruz, G., & Vázquez‐Prado, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216427 · Cited by 3
AMBRA1 and FAK1: crosstalking for improved targeted therapy in melanoma
Leo, L. D., & Zio, D. D. (2021) · Molecular & Cellular Oncology · doi:10.1080/23723556.2021.1949955 · Cited by 3
Enhanced Gαq Signaling in TSC2 -Deficient Cells Is Required for Their Neoplastic Behavior
Trefier, A., Tousson-Abouelazm, N., Yamani, L., Ibrahim, S., Joung, K.-B., Pietrobon, A., Yockell‐Lelièvre, J., Hébert, T. E., Ladak, R. J., Takano, T., et al. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0111oc · Cited by 3
Long Noncoding RNA SAMMSON Promotes Melanoma Progression by Inhibiting FOXA2 Expression
Yang, L., Zhou, M., Wang, S., Yi, X., Xiong, G., Cheng, J., Sai, B., Zhang, Q., Yang, Z., Kuang, Y., et al. (2023) · Stem Cells International · doi:10.1155/2023/8934210 · Cited by 3
RetractedTranscriptomic Analysis of Metastatic Uveal Melanoma and Differences in Male and Female Patients
Doddi, S., Hamoud, A.-R. A., Eby, H., Zhang, X., Imami, A. S., Shedroff, E., Schiefer, I. T., MORENO-LOPEZ, J., Gamm, D. M., Meller, J., et al. (2024) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20452 · Cited by 2
Tchakal-Mesbahi, A., He, J., Zhu, S., Huang, M., Fukushima, K., Bouley, R., Brown, D., & Lu, H. A. J. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00091.2025 · Cited by 3
Zhao, L., Han, Y., Du, J., & Zhao, X. (2026) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2026.113170 · Cited by 2
Functional genomic screens uncover FERMT2 as a critical regulator of YAP/TAZ-driven tumorigenicity
Chiesa, A., Poli, V., Croci, O., Biagioni, F., Fuentes, P., Marenda, M., Dondi, A., Rodighiero, S., Filipuzzi, M., Sberna, S., et al. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01694-w · Cited by 3
Chen, X., Hu, L., Mao, X., Chen, H., She, Y., Chi, H., Zeng, H., Guo, L., & Han, Y. (2022) · Journal of Oncology · doi:10.1155/2022/1608936 · Cited by 2
Dwyer, M. B., Luo, J., Todd, T. D., Blumer, K., Tall, G. G., & Wedegaertner, P. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108426 · Cited by 2
Yang, Z. H., Ma, L., Fu, Y., He, X., Luo, Y., Ge, S., Jia, R., Huang, J., & Fan, X. (2025) · Research · doi:10.34133/research.0896 · Cited by 2
Lubrano, S., Cervantes‐Villagrana, R. D., Arang, N., Officer, A., Adame-Garcia, S. R., Cuesta-Margolles, G., Aplin, A. E., & Gutkind, J. S. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110712 · Cited by 2
Self-citationVargas, P. P., Arias-García, M., Roumeliotis, T. I., Choudhary, J. S., & Bakal, C. (2020) · SSRN Electronic Journal · doi:10.1101/2020.07.24.218313 · Cited by 2
Signaling, Physiology, and Targeting of GPCR ‐Regulated Phospholipase C Enzymes
Chandan, N. R., Smrcka, A. V., & Phan, H. T. N. (2022) · doi:10.1002/9781119564782.ch14 · Cited by 2
Lubrano, S., Cervantes‐Villagrana, R. D., Arang, N., Cardenas-Alcoser, E. S., Sato, K., Cuesta-Margolles, G., Paradis, J. S., Acosta, M., & Gutkind, J. S. (2025) · Cancers · doi:10.3390/cancers18010074 · Cited by 1
Self-citationHu, Z., Majeski, H. E., Mestre‐Farrera, A., Cai, S., Lalezarzadeh, A., Zhang, Y., Arimoto, K., Zhang, D., Piwnica-Worms, H. M., Fattet, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-70518-9 · Cited by 1
Woodard, G. E., Jardín, I., & Rosado, J. A. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118108 · Cited by 1
Glucose Metabolism in Immune Regulation: From Mechanisms to Therapeutic Opportunities
Malemnganba, T., Pandey, A. K., Kar, S., & Prajapati, V. K. (2026) · Journal of Cellular Biochemistry · doi:10.1002/jcb.70111 · Cited by 2
Improving therapy in metastatic uveal melanoma by understanding prior failures
Olson, D. J., & Luke, J. J. (2020) · Oncoscience · doi:10.18632/oncoscience.510 · Cited by 1
Oncogenic Gαq activates RhoJ through PDZ-RhoGEF
Cervantes‐Villagrana, R. D., Color-Aparicio, V. M., Castillo‐Kauil, A., García‐Jiménez, I., Beltrán‐Navarro, Y. M., Reyes‐Cruz, G., & Vázquez‐Prado, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115734 · Cited by 1
Intraocular and Orbital Cancers
Lambert-Cheatham, N. A., Jusufbegovic, D., & Corson, T. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00024-4 · Cited by 1
Present Status of the Therapeutic Approaches to Treat Uveal Melanoma
Mandal, A., Varghese, M. V., & James, J. (2022) · Handbook of Oxidative Stress in Cancer: Therapeutic Aspects · doi:10.1007/978-981-16-5422-0_199 · Cited by 1
A luciferase fragment complementation assay to detect focal adhesion kinase (FAK) signaling events
Estep, J. A., Sun, L. O., & Riccomagno, M. M. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e15282 · Cited by 1
Lee, J. S., Nair, N. U., Chapman, L. M., Sinha, S., Wang, K., Cha, H., Rubin, E., Berger, R., Lazar, V., Kurzrock, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.16.951699 · Cited by 1
Self-citationWang, X., & Wang, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.03.502677 · Cited by 1
AACR 2019 — Congrès de l’association américaine de recherche contre le cancer
Pudlarz, T., Naoun, N., Beinse, G., Soares, D. G., & Lotz, J. (2019) · ONCOLOGIE · doi:10.3166/onco-2019-0036
Metadata
- Authors
- Feng, X., Arang, N., Rigiracciolo, D. C., Lee, J. S., Yeerna, H., Wang, Z., Lubrano, S., Kishore, A., Pachter, J. A., König, G. M., Maggiolini, M., Kostenis, E., Schlaepfer, D. D., Tamayo, P., Chen, Q., Ruppin, E., & Gutkind, J. S.
- Affiliations
- Sichuan University (CN)
- University of California San Diego (US)
- National Institutes of Health (US)
- Verastem (United States) (US)
- University of Bonn (DE)
- University of Calabria (IT)
- Corresponding author
- Lee, Joo Sang
- Chen, Qianming
- Ruppin, Eytan
- Gutkind, J. Silvio
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 35
- Issue
- 3
- Pages
- 457-472.e5
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC6737937
- OpenAlex
- W2911710737
- Cited by
- 237
- References
- 71
- Citations by year
- 2026: 14 · 2025: 22 · 2024: 31 · 2023: 40 · 2022: 36 · 2021: 40 · 2020: 37 · 2019: 17
- FWCI
- 17.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Archive of Doctoral Theses and Digital Collections (University of Calabria) (submittedVersion)
- Funders
- NIH (R33CA225291, U01CA217885, P30 CA023100, R01HG009285, 10193SC, CA209891, CA102310, T32GM007752)
- DGE (1650112, T32CA067754-22)
- MOE (B14038)
- National Natural Science Foundation (81672677, 81520108009, 81621062)
- AIRC (IG 21322)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- uveal melanoma, GNAQ, GNA11, focal adhesion kinase, synthetic lethality, Hippo signaling pathway, YAP, MOB1, tyrosine phosphorylation, therapeutic target
- MeSH terms
- Hippo Signaling Pathway, Uveal Melanoma, Animals, Genes, Lethal, Humans, Melanoma, Neoplasm Transplantation, Phosphorylation, Prognosis, Uveal Neoplasms, Signal Transduction, Survival Analysis, Protein Serine-Threonine Kinases, Computational Biology, GTP-Binding Protein alpha Subunits, Gq-G11, Cell Line, Tumor, Cell Proliferation, Mice, Focal Adhesion Kinase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review